ALADDIN Study - Phase III: Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (VP-AD-301)
Clinical trial NCT00231946 · COMPLETED
Trial details
- NCT number
- NCT00231946
- Sponsor
- Voyager Pharmaceutical Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-09-01
- Enrollment
- 555
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.